(19)
(11) EP 4 815 990 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24898733.1

(22) Date of filing: 27.11.2024
(51) International Patent Classification (IPC): 
A61K 45/00(2006.01)
A61P 35/00(2006.01)
C12Q 1/6886(2018.01)
A61K 45/06(2006.01)
C12Q 1/6883(2018.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; C12Q 1/6886; C12Q 2600/156; C12Q 2600/106; A61K 31/427; A61K 31/495; C12Y 305/03006; C12Y 305/03001; A61K 38/50
 
C-Sets:
A61K 31/495, A61K 2300/00;
(86) International application number:
PCT/US2024/057684
(87) International publication number:
WO 2025/117694 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 29.11.2023 US 202363604084 P

(71) Applicant: Cedars-Sinai Medical Center
Los Angeles, CA 90048 (US)

(72) Inventors:
  • BREUNIG, Joshua
    Beverly Hills, California 90210 (US)
  • RINCON FERNANDEZ PACHECO, David
    Los Angeles, California 90064 (US)

(74) Representative: Hutter, Anton 
Venner Shipley LLP 5 Stirling House Stirling Road The Surrey Research Park
Guildford GU2 7RF
Guildford GU2 7RF (GB)

   


(54) TARGETED METABOLIC THERAPIES FOR G34R GLIOMAS